Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. ANSATIPINE (rifabutine)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

ANSATIPINE (rifabutine)

Medicine - Posted on Dec 10 2015 - Updated on Jun 12 2019
Active substance (DCI)
  • rifabutine
history (3)
  • 11/25/15

    ANSATIPINE (rifabutine)

    Maintien du remboursement dans les mêmes conditions
    icône flèche
  • 3/31/10

    ANSATIPINE (rifabutine)

    ANSATIPINE (rifabutine)
    icône flèche
  • 7/20/05

    ANSATIPINE 150 mg, gélule (Boîte de 30 (code CIP : 336 069-6))

    ANSATIPINE 150 mg, gélule (Boîte de 30 (code CIP : 336 069-6))
    icône flèche
Technical information
ATC code
  • J04AB04
Manufacturer
SERB
Presentation

ANSATIPINE 150 mg, gélule (code CIS : 67699269) - plaquette(s) thermoformée(s) PVC-aluminium de 30 gélule(s) - Code CIP : 3400933606961

All our publications
    Bacterial infections Drug therapy Immunologic deficiency syndromes Sexually transmitted diseases Virus diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
TwknYTyVJLDXfLKD